Mesoblast Ltd News

Mesoblast Ltd: MSB Annual Financial Results and Operational Update

Aug 29 06:16

Mesoblast Ltd: Mesoblast 2024 Full Year Financial Results Webcast

Aug 28 06:53

Mesoblast Ltd: Class Action Resolution

Aug 21 17:07

Mesoblast Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 31 07:53

Mesoblast Ltd: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L

Jul 23 12:18

Mesoblast Ltd: Confirmatory Phase 3 Back Pain Trial Actively Enrols

Jul 22 07:07

Mesoblast Ltd: Appendix 3Y for Philip Krause

Jul 12 15:27

Mesoblast Ltd: Mesoblast Resubmits BLA with FDA for Ryoncil Approval

Jul 9 07:55

Mesoblast Ltd: Mesoblast to File BLA for Ryoncil FDA Approval Next Week

Jul 1 13:00

Mesoblast Ltd: Mesoblast Corporate Presentation at Investor Conference

Jun 3 07:27

Mesoblast Ltd: Appendix 3Y for Eric Rose

May 10 07:22

Mesoblast Ltd: Appendix 3Y for Eric Rose

May 3 07:49

Mesoblast Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 07:59

Mesoblast Ltd: Mesoblast Chair Transition

Apr 30 07:47

Mesoblast Ltd: Appendix 3Y for Jane Bell

Apr 16 07:18

Mesoblast Ltd: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA

Mar 26 10:05

Mesoblast Ltd: Pause in Trading

Mar 26 06:52

Mesoblast Ltd: FDA Supports Accelerated Approval Pathway for Heart Failure

Mar 11 06:57

Mesoblast Ltd: Mesoblast 2024 Half Year Financial Results Webcast

Feb 26 14:00

Mesoblast Ltd: FDA Grants Orphan Drug Designation for Revascor

Feb 15 07:46